Evidence map›Paper›PMID 41321721›Full record

ArticleChemical science2026

High-valent sulfur fluorides as reactivity switches for PFAS-free benzene-azepine skeletal editing.

Chavakula Nagababu, Takuya Muramatsu, Muhamad Zulfaqar Bacho, Shiwei Wu, Seishu Ochiai, Jorge Escorihuela, Norio Shibata

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Asymmetric hydrogenation of 3Chemical science · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chavakula NagababuDepartment of Nanopharmaceutical Sciences, Nagoya Institute of Technology Gokiso, Showa-ku Nagoya 466-8555 Japan nozshiba@nitech.ac.jp.
Takuya MuramatsuDepartment of Engineering, Nagoya Institute of Technology Gokiso, Showa-ku Nagoya 466-8555 Japan.
Muhamad Zulfaqar BachoDepartment of Nanopharmaceutical Sciences, Nagoya Institute of Technology Gokiso, Showa-ku Nagoya 466-8555 Japan nozshiba@nitech.ac.jp.ORCID https://orcid.org/0000-0002-6595-7490
Shiwei WuDepartment of Engineering, Nagoya Institute of Technology Gokiso, Showa-ku Nagoya 466-8555 Japan.
Seishu OchiaiDepartment of Engineering, Nagoya Institute of Technology Gokiso, Showa-ku Nagoya 466-8555 Japan.
Jorge EscorihuelaDepartamento de Química Orgánica, Universitat de València Avda. Vicente Andrés Estellés s/n Burjassot 46100 Valencia Spain.ORCID https://orcid.org/0000-0001-6756-0991
Norio ShibataDepartment of Nanopharmaceutical Sciences, Nagoya Institute of Technology Gokiso, Showa-ku Nagoya 466-8555 Japan nozshiba@nitech.ac.jp.ORCID https://orcid.org/0000-0002-3742-4064

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of non-PFAS fluorinated heterocycles is a critical challenge in sustainable molecular design. Here we report a reactivity-switching skeletal editing strategy that transforms benzenes into azepines through visible-light activation mediated by high-valent sulfur fluorides. The pentafluorosulfanyl (SF

Identifiers

PMID41321721
PMCPMC12659759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.